دورية أكاديمية

ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants

التفاصيل البيبلوغرافية
العنوان: ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants
المؤلفون: Luo X., Feurstein S., Mohan S., Porter C. C., Jackson S. A., Keel S., Chicka M., Brown A. L., Kesserwan C., Agarwal A., Luo M., Li Z., Ross J. E., Baliakas P., Pineda-Alvarez D., DiNardo C. D., Bertuch A. A., Mehta N., Vulliamy T., Wang Y., Nichols K. E., Malcovati L., Walsh M. F., Rawlings L. H., McWeeney S. K., Soulier J., Raimbault A., Routbort M. J., Zhang L., Ryan G., Speck N. A., Plon S. E., Wu D., Godley L. A.
المساهمون: Luo, X., Feurstein, S., Mohan, S., Porter, C. C., Jackson, S. A., Keel, S., Chicka, M., Brown, A. L., Kesserwan, C., Agarwal, A., Luo, M., Li, Z., Ross, J. E., Baliakas, P., Pineda-Alvarez, D., Dinardo, C. D., Bertuch, A. A., Mehta, N., Vulliamy, T., Wang, Y., Nichols, K. E., Malcovati, L., Walsh, M. F., Rawlings, L. H., Mcweeney, S. K., Soulier, J., Raimbault, A., Routbort, M. J., Zhang, L., Ryan, G., Speck, N. A., Plon, S. E., Wu, D., Godley, L. A.
سنة النشر: 2019
المجموعة: IRIS UNIPV (Università degli studi di Pavia)
مصطلحات موضوعية: Myeloid neoplasm, germline predisposition, Mutation, RUNX1
الوصف: Standardized variant curation is essential for clinical care recommendations for patients with inherited disorders. Clinical Genome Resource (ClinGen) variant curation expert panels are developing disease-associated gene specifications using the 2015 American College of Medical Genetics and Genomics (ACMG) and Association for Molecular Pathology (AMP) guidelines to reduce curation discrepancies. The ClinGen Myeloid Malignancy Variant Curation Expert Panel (MM-VCEP) was created collaboratively between the American Society of Hematology and ClinGen to perform gene- and disease-specific modifications for inherited myeloid malignancies. The MM-VCEP began optimizing ACMG/AMP rules for RUNX1 because many germline variants have been described in patients with familial platelet disorder with a predisposition to acute myeloid leukemia, characterized by thrombocytopenia, platelet functional/ultrastructural defects, and a predisposition to hematologic malignancies. The 28 ACMG/AMP codes were tailored for RUNX1 variants by modifying gene/disease specifications, incorporating strength adjustments of existing rules, or both. Key specifications included calculation of minor allele frequency thresholds, formulating a semi-quantitative approach to counting multiple independent variant occurrences, identifying functional domains and mutational hotspots, establishing functional assay thresholds, and characterizing phenotype-specific guidelines. Preliminary rules were tested by using a pilot set of 52 variants; among these, 50 were previously
نوع الوثيقة: article in journal/newspaper
وصف الملف: STAMPA
اللغة: English
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31648317; info:eu-repo/semantics/altIdentifier/wos/WOS:000492438500005; volume:3; issue:20; firstpage:2962; lastpage:2979; numberofpages:18; journal:BLOOD ADVANCES; http://hdl.handle.net/11571/1340759Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85074943048
DOI: 10.1182/bloodadvances.2019000644
الإتاحة: https://doi.org/10.1182/bloodadvances.2019000644Test
http://hdl.handle.net/11571/1340759Test
رقم الانضمام: edsbas.CB23C423
قاعدة البيانات: BASE